NCT00555048 2017-05-24Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerFred Hutchinson Cancer CenterPhase 1/2 Terminated1 enrolled 5 charts
NCT01118013 2017-03-24Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantAlliance for Clinical Trials in OncologyPhase 2 Terminated6 enrolled 5 charts